Literature DB >> 8145038

Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity.

D P Dubey1, C A Alper, N M Mirza, Z Awdeh, E J Yunis.   

Abstract

We demonstrated earlier that individuals homozygous for conserved major histocompatibility complex (MHC)-extended haplotypes have low natural killer (NK) activity as measured by cytolysis of the K562 tumor cell lines. In the present study, we investigated the segregation and MHC linkage of NK activity in families in which MHC haplotypes of human histocompatibility leukocyte antigens (HLA)-A, -C, and -B, complotype, and DR specificities are known. In two informative families, low activity was inherited as a recessive trait linked to the MHC. By using individuals homozygous for specific fragments of extended haplotypes or for HLA-B alleles, we found that the HLA-C and -B and not the complotype or HLA-DR region contains genes controlling NK activity. The majority of the unrelated individuals with low NK activity were homozygous or doubly heterozygous for HLA-B7 (Cw7), B8 (Cw7), B44 (Cw5), B18, or B57 (Cw6). Thus, these alleles form one complementation group designated NKB1. Another less frequent group, NKB2, was also identified, and consisted of individuals homozygous for B35 (Cw4). NK activity was correlated with the number of circulating NK (CD16+ CD56+) cells. Individuals homozygous for the NKB complementation groups have fewer circulating NK cells than individuals heterozygous for these alleles and alleles of other complementation groups, possibly explaining the low activity of cells in these subjects. These findings suggest that during the maturation of NK cells there is NK cellular deletion in donors homozygous for NKB genes resulting in low NK cell numbers and activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145038      PMCID: PMC2191452          DOI: 10.1084/jem.179.4.1193

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  A test for segregation ratios in family data.

Authors:  C A SMITH
Journal:  Ann Hum Genet       Date:  1956-05       Impact factor: 1.670

2.  Natural killer susceptibility of human cells may be regulated by genes in the HLA region on chromosome 6.

Authors:  A Harel-Bellan; A Quillet; C Marchiol; R DeMars; T Tursz; D Fradelizi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts.

Authors:  R Kiessling; P S Hochman; O Haller; G M Shearer; H Wigzell; G Cudkowicz
Journal:  Eur J Immunol       Date:  1977-09       Impact factor: 5.532

4.  Centroid cluster analysis of the primed lymphocyte test.

Authors:  P G Carroll; W C DeWolf; C R Mehta; J E Rohan; E J Yunis
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

Review 5.  Biology and genetics of hybrid resistance.

Authors:  M Bennett
Journal:  Adv Immunol       Date:  1987       Impact factor: 3.543

6.  Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.

Authors:  R M Rembecki; V Kumar; C S David; M Bennett
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.

Authors:  R M Rembecki; M Bennett; V Kumar; T A Potter
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

8.  Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.

Authors:  H F Pross; M G Baines; P Rubin; P Shragge; M S Patterson
Journal:  J Clin Immunol       Date:  1981-01       Impact factor: 8.317

9.  Polymorphism of Hh-1, the mouse hemopoietic histocompatibility locus.

Authors:  R M Rembecki; V Kumar; C S David; M Bennett
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  5 in total

1.  HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.

Authors:  Zaheed Husain; Edward Levitan; Charles E Larsen; Nadeem M Mirza; Souhad Younes; Edmond J Yunis; Chester A Alper; Devendra P Dubey
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

2.  HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Authors:  B C Healy; M Liguori; D Tran; T Chitnis; B Glanz; C Wolfish; S Gauthier; G Buckle; M Houtchens; L Stazzone; S Khoury; R Hartzmann; M Fernandez-Vina; D A Hafler; H L Weiner; C R G Guttmann; P L De Jager
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

3.  Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.

Authors:  Samuel O Pine; James G Kublin; Scott M Hammer; Joleen Borgerding; Yunda Huang; Danilo R Casimiro; M Juliana McElrath
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

4.  Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?

Authors:  Donald J Lehmann; Martin C N M Barnardo; Susan Fuggle; Isabel Quiroga; Andrew Sutherland; Donald R Warden; Lin Barnetson; Roger Horton; Stephan Beck; A David Smith
Journal:  J Neuroinflammation       Date:  2006-12-18       Impact factor: 8.322

5.  Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data.

Authors:  Tulsi A Malavia; Srilakshmi Chaparala; Joel Wood; Kodavali Chowdari; Konasale M Prasad; Lora McClain; Anil G Jegga; Madhavi K Ganapathiraju; Vishwajit L Nimgaonkar
Journal:  NPJ Schizophr       Date:  2017-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.